Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
Pfizer will "no longer initiate new clinical trials in Russia, and we will stop recruiting new patients in our ongoing clinical trials in the country."
Women and men used social media to share their stories over the weekend about how they quit the transgender ideology being pushed by teachers, progressives, corporations, and President Joe Biden’s far-left government deputies.